Health News

More Consumers are Buying Frozen Seafood to Cook due to Seafood’s Health Benefits – Why Frozen is the New Fresh

 
Mark Shinbane, President and CEO of Harvest of the Sea, a pioneer and world leader in high quality, innovative seafood products joins eHealth Radio and the Health News and Nutrition Channels.
Listen to host Eric Dye & guest Mark Shinbane discuss the following:
We hear that frozen seafood is hitting record sales in the U.S. as more households are continuing to buy frozen seafood that is conveniently ready-to-cook. Tell us about some of these record-breaking seafood consumption statistics.
Many consumers think that wild-caught seafood is better for consumption. Can you talk to us about a couple of myth busters: wild versus farm-raised? fresh vs. frozen seafood?
Where did the idea for Seafood Medley come from? 


Preparing seafood might seem more difficult than cooking a chicken breast. What is the level of difficulty for cooking chicken vs. your Seafood Medley of scallops, calamari, shrimp and mussels?
Where can consumers purchase Seafood Medley?
For over 60 years, Harvest of the Sea has been a pioneer and world leader in high quality, innovative seafood products, reflecting the core values of founder Bill Shinbane and his family that continue to drive industry standards today.
​At the helm of Harvest of the Sea is President and CEO Mark Shinbane who assumed leadership of the company in 2004. Mark’s journey to the top position began as many do in family-owned businesses – at the bottom, working his way up at every level of the company’s operations. As a boy, Mark started with sweeping floors and continued year-after-year to learn every aspect of the business: unloading trucks in the warehouse, manning the production line, working in the Quality Assurance lab and studying the complexities of importing and manufacturing.
​By the time Mark graduated from University of California, Los Angeles with a B.S. in Economics and Accounting, he also had the equivalent of a “degree” in seafood manufacturing. After a brief stint at an accounting firm, he agreed to join Harvest of the Sea and work full-time with his father. Mark’s accounting and technological acumen benefitted the company at a critical time in its expansion, bringing new systems and processes to the firm that kept the company on a steady growth track. Today, Harvest of the Sea is a multi-million-dollar seafood supplier to some of the country’s best-known retailers and restaurant operators.
Throughout his career, Mark and his team of culinary specialists have focused on delivering unique, high-value and innovative products to consumers – seafood dishes that are not only delicious but easy for anyone to prepare. It’s a winning formula that has enabled Mark to grow the firm despite intermittent industry challenges and the country’s ever-changing economic cycles.
When he is not solving problems and developing new products with his creative team and overseas partners, Mark relaxes with his passion for audio and music and spends time with his family attending concerts, sporting events, hiking and traveling. Additionally, he enjoys sports cars and driving the many scenic roads throughout Los Angeles and up the Pacific Coast. Mark is also a widely respected and active member of local business groups. For the past 6 years, he has been the Chairman of the L.A. Downtown Industrial Business Improvement District and an active member of his local business association for over 30 years.
 
 
Website: https://harvestsea.com 
Social Media Links: Instagram: https://instagram.com/harvestofthesea Facebook: https://facebook.com/harvestofthesea Linkedin: https://linkedin.com/company/harvestsea 

Beautifi - Making Health & Beauty Affordable

 
 
Ryan Brinkhurst the CEO and Founder of Beautifi - Making Health & Beauty Affordable joins eHealth Radio and the Beauty and Health News Channels. Ryan is a notable entrepreneur with four successful businesses, holding a business management and finance background.
Listen to host Eric Dye & guest Ryan Brinkhurst discuss the following:
What is Beautifi’s role in the healthcare industry and how is it making an impact?
Could you explain to our audience the application process for plastic surgery financing?
What are some of the most common medical procedures that have finance options available?


How can practitioners partner with Beautifi to reach potential patients in Canada?
Is there anything else you would like our audience to know about Beautifi, and where can they connect with you? 
Ryan Brinkhurst was born and raised in Vancouver and graduated from UBC’s Sauder School of Business with honours in 2014, obtaining a Bachelor of Commerce specializing in Finance. Ryan worked as a Management Consultant for 3 years but is now branded as a “Serial Entrepreneur” having successfully launched 4 businesses in the last 3 years which currently employ over 30 staff. Ryan holds his Chartered Financial Analyst (CFA) designation and is an active investor and advisor to young entrepreneurs.
 
 
Website: https://beautifi.com 
Social Media Links: Instagram: @beautifisolutionsFacebook: https://facebook.com/beautifisolutions Twitter: @Beautifi_

Dr. Michael Turner: Your go to for all things health and wellness

 
 
Dr. Michael K. Turner an Integrative Medicine Physician and Men’s Health Specialist based in Tri-Cities, Washington joins eHealth Radio and the Covid-19 Information and Health News Channels. Called “genuine,” “caring,” and “the best doctor in the world” by patients, Dr. Turner brings a high degree of empathy, trademark optimism, and in-depth expertise to his practice.
Listen to host Eric Dye & guest Dr. Michael K. Turner discuss the following:
You have a very well rounded practice with extensive studies in many lanes. What would you say is your favorite area of expertise? What is your East meets West approach?
Talk to us about when Covid hit and how did you pivot during that time in your practice?
Tell us your research and data on treating patients with Ivermectin.


We saw you put out a Covid prevention plan and treatment plan, tell us how one prevents contracting Covid.
What about your telemedicine platform. What types of patients would benefit from this and do you see this as the future for medicine practice?
Patients seek you out from all over the country. What is the one advice you want to share with every one on keeping healthy during this time. 
Dr. Michael K. Turner is an Integrative Medicine Physician and Men’s Health Specialist based in Tri-Cities, Washington. Called “genuine,” “caring,” and “the best doctor in the world” by patients, he brings a high degree of empathy, trademark optimism, and in-depth expertise to his practice. Providing world-class health/wellness advice on topics that include holistic COVID care and chronic illness, he harnesses modern developments in medicine to bring patients the best care possible via in-office or telehealth appointment options.
Earning his undergraduate degree at Stanford University, Dr. Turner went on to earn his Doctor of Medicine from Harvard Medical School with a residency at the Mayo Clinic. With over a decade of clinical experience, along with a background in both hospital-based and private practice, he couples a research-based approach with a unique passion for excellence as he helps to develop the growing field of integrative/holistic medicine. His current areas of expertise include advanced treatments in sports medicine and anti-aging, along with chronic illness, nerve disorders, and general health.
Dr. Turner is one of the nation’s few male doctors with an in-depth knowledge of chronic illnesses, such as Chronic Fatigue Syndrome (CFS), Epstein Barr Virus (EBV), Hashimoto’s Disease, Cushing’s Disease, and COVID-19 Long Haul effects. His journey into the complex world of these “invisible” conditions - often overlooked or misdiagnosed - began when his wife received a diagnosis of cancer and chronic illness. Symptoms like exhaustion, brain fog, or fatigue are often misconstrued as signs of hormone imbalance or depression, particularly in female patients. Living in the wake of these diseases and their symptoms, Dr. Turner sought to understand them at a DNA level, searching for the most effective answers.
Today, as COVID Long Haul affects an increasing number of Americans, Dr. Turner works alongside patients, digging for the real root causes and best courses of treatment. He offers research-based expertise on controversial topics such as Ivermectin, the pro’s/con’s of vaccines, and holistic/natural care approaches, as well as the challenges of medical censorship/cancel culture. He also advises patients on outpatient prevention/treatment options, so they can increase the odds of staying well at home and avoiding a trip to the E.R. Dr. Turner proudly serves the Richland, Kennewick, Pasco, and surrounding communities.
Website: https://michaelturnermd.com 
Social Media Links: Instagram: https://instagram.com/michaelturnermd  Facebook: https://facebook.com/drmichaelkturner  Twitter: https://twitter.com/MichaelTurnerM4 

Innovative Market Access and Product Life Cycle Solutions for Life Sciences with AscellaHealth

 
Michael Baldzicki, Chief Brand Officer at AscellaHealth, a global specialty pharmacy and healthcare solutions company joins eHealth Radio and the Healthcare and Pharmaceutical Information Channels to talk about the company’s comprehensive suite of Specialty Pharmacy services for pharmaceutical/biotech manufacturers.
Listen to interview with host Eric Michaels and guest Michael Baldzicki discuss the following:
Can you give our listeners information on your background and role with AscellaHealth?
Please describe the AscellaHealth business model and how the company serves life sciences in the specialty pharmacy and healthcare industry. 
AscellaHealth has an exciting new strategic alliance with Optime Care. Can you tell our listeners what this partnership means for others in the industry?
AscellaHealth recently came out with some expanded services. Can you explain these new offerings and their benefits for key market segments that AscellaHealth serves?  
In the current healthcare environment, it seems people are lacking customizable options. Can you speak to the flexibility of AscellaHealth’s solutions and how this ultimately serves to enhance outcomes of branded products?
As chief brand officer for AscellaHealth, Mike ensures the success of the widest variety of strategic projects across departmental segments, and other business development initiatives that cultivate opportunities that affect client segments.
With more than 21+ years of specialty pharmacy, pharmaceutical and biotech industry experience, including roles in national and regional managed markets, specialty supply channels, sales management and specialty brand management. Mike offers strategic insight into specialty pharmacy trends, distribution, contracting, reimbursement, and the application of health outcomes and economic evidence to prove value proposition. He is a recognized leader in the specialty pharmaceutical market for developing and implementing key payer and specialty pharmacy agreements that result in documented savings for specialty market segments.
Mike is active in the biotech community and is an advisor/faculty member of the Academy of Managed Care Pharmacy (AMCP) for Specialty Pharmacy Advisory Group & Biosimilars Partnership Forum, NCPDP Specialty Pharmacy Stakeholder Action Group, Faulty Board Member of the American Journal of Managed Care (AJMC) Specialty Pharmacy for ACOs and was 2014 Editorial Board Member for Specialty Pharmacy Times.
He has published abstracts and articles surrounding plasma-based infusion therapy, and managed markets and specialty pharmacy. He has spoken at a variety of seminars and WebEx’s within specialty groups and other industry related settings.
Mike earned a Bachelor of Arts in Business Management and a Certificate in Clinical Research Compliance and Management (CRCM). He has completed programs in leadership development at Harvard University, Brooks Group, Miller Heiman Account Management and MD Anderson Center Cancer Courses.
 
 
Website: https://ascellahealth.com 
Linkedin: https://linkedin.com/company/ascellahealth 

An Opportunity to Lower Medical Costs

 
Christine Cooper, the CEO of aequum LLC and the Co-Managing Member of Koehler Fitzgerald LLC, a law firm with a national practice along with Jack Towarnicky an ERISA/Employee Benefits compliance and planning attorney, having over forty years of experience in human resources and plan sponsor leadership roles joins eHealth Radio and the Healthcare and Legal Channels.
Listen to interview with host Eric Michaels and guests Christine Cooper & Jack Towarnicky discuss the following:
Christine, will the No Surprises Act protections against balance billing save workers money?
Jack, surveys show a majority of Americans are concerned about medical bills.  Won’t the No Surprises Act eliminate those concerns?
How can employers help alleviate “financial fragility” when it comes to the medical expenses their employees are not prepared to pay?
How could health care consumerism potentially transform future health care coverage?
What resources and services are available to help participants in a health plan defend against receiving unreasonable or excessive medical billing?
 
Christine M. Cooper, CEO and Member, aequum LLC
Christine M. Cooper is the CEO and Member, of aequum LLC. A patent lawyer recruited to Koehler Fitzgerald LLC in 2016 because of her large law firm experience and IT skills, Christine was quickly elevated to a member of Koehler Fitzgerald LLC and leads the health care practice. Christine is the CEO of aequum and is dedicated to assisting and defending plans and patients.
Jack Towarnicky Member, aequum LLC
As an ERISA/Employee Benefits compliance and planning attorney, Jack has over forty years of experience in human resources and plan sponsor leadership roles. This includes twenty-five years as the leader of a Fortune 100 corporation’s benefits function. While serving in those roles, Jack and his team won a multitude of individual, team and corporate recognitions. In 2020 Jack joined aequum and provides plan drafting and compliance services to employers and plan sponsors.
About aequum
Founded in 2020, aequum LLC serves third-party administrators, medical cost management companies, stop-loss carriers, employer-sponsored health plans and brokers nationwide to protect plan participants, improve employee satisfaction with their health care plans, and generate plan and participant cost savings. aequum helps patients defend medical balance bills and brings savings to employer-sponsored health plans by providing administrative and other services to its partners. In addition, its sister organization, Koehler Fitzgerald LLC, provides legal advocacy to plan participants.
Website: https://aequumhealth.com 
Social Media Links: Facebook: https://facebook.com/aequumbykoehlerfitzgerald Linkedin: https://linkedin.com/company/aequumllc/about Twitter: https://twitter.com/aequumhealth 
 

Masks are coming off in some states and COVID-19 is here to stay

 
 
Dr. Nooristani, a licensed medical doctor with 16 years of experience practicing medicine and the CEO of Balance7 and also head and board member of the non profits Slo Noor Foundation & Saviehealth joins eHealth Radio and the Covid-19 Information and Health News Channels.
Listen to host Eric Dye & guest Dr. Nooristani discuss the following:
Should we continue to wear masks?
Do people still need to be vaccinated?
For those of us that are vaccinated should we get the booster?
Are there new treatments?
Are we safe to attend large gatherings?
Dr. Nooristani is a licensed medical doctor with 16 years of experience practicing medicine and is the CEO of Balance7 and also head and board member of the non profits below:
Slo Noor Foundation has been operational for the past 10 years and has delivered over 30 million dollars’ worth of free care to the un-insured population in San Luis Obispo County and surrounding areas. Thousands of lives have been saved over the years simply by caring for those in desperate need of health care.
Saviehealth is opening its door for the uninsured population in Santa Barbara and surrounding counties to bridge the gap and deliver high quality medical services free of charge. Both organizations are operational in large part because of volunteers, including healthcare workers such as physicians and nurses.
Balance7 is a great resource for health tips, recipes, workouts and general questions to live a better, more fulfilling life.
 
 
Website: https://balance7.com 
Non-Profits: Slo Noor Foundation: https://slonoorfoundation.org  Saviehealth: https://saviehealth.org 

The First New Ischemic Stroke Treatment in 25 years by DiaMedica Therapeutics

 
 
Rick Pauls, President and CEO of DiaMedica Therapeutics, a clinical-stage biopharma committed to improving the lives of people suffering serious diseases, with initial focus on acute ischemic stroke (AIS) and chronic kidney disease (CKD) joins eHealth Radio and the Health News Channel.
Listen to host Eric Dye & guest Rick Pauls discuss the following:
DiaMedica is currently enrolling for a phase 3 clinical trial for an ischemic stroke treatment that is able to be administered to patients within 24 hours of the onset of symptoms. Compared to the current treatment of over 25 years with only a 4-hour window, can you enlighten listeners on how this science is disrupting the trajectory of stroke therapy?
DiaMedica's lead candidate, DM199, is a synthetic form of the KLK1 protein, an established therapeutic modality for the treatment of acute ischemic stroke and chronic kidney disease. A form of human KLK1, isolated from human urine, is approved in China for subacute treatment of AIS. As of now, in the U.S., only an IV injection of recombinant tissue plasminogen activator (TPA) is the standard treatment for ischemic stroke. Can you expand on how DiaMedica's recombinant protein replacement therapy works?
What is unique about the company's drug and trial design is that you plan to assess two separate clinically meaningful endpoints, stroke recoveries and prevention of ischemic stroke recurrence, across the same study population. What are the clinical benefits of this structure?
DiaMedica is currently enrolling at ten clinical trial sites across the country. Why is it advantageous for listeners to know which local hospital is participating in the first new ischemic stroke treatment in 25 years?
The FDA granted Fast Track Designation to DM199 for the treatment of AIS in September 2021. Fast Track is a process intended to facilitate the development and expedite the review of investigational drugs for the treatment of serious or life-threatening conditions where there is a significant unmet medical need. What are the next steps here, and what timeline are we looking at for phase 3 data?
Rick Pauls was appointed President and Chief Executive Officer of DiaMedica Therapeutics in July 2009. Mr. Pauls has served as a member of DiaMedica’s board of directors since April 2005 and as the Chairman of the Board from April 2008 to July 2014. Before joining DiaMedica, Mr. Pauls was the Co-Founder and Managing Director of CentreStone Ventures, an early-stage life sciences venture capital fund, from February 2002 until January 2010. Mr. Pauls was an analyst for Centara Corporation, an early-stage venture capital fund, from January 2000 until January 2002. From June 1997 until November 1999, Mr. Pauls worked for General Motors Acceptance Corporation specializing in asset-backed securitization and structured finance. Additionally, Mr. Pauls has served on the board of directors of several public and private companies. Mr. Pauls received his B.A. in Economics from the University of Manitoba and his M.B.A. in Finance from the University of North Dakota.
 
 
Website: https://diamedica.com
Social Media Links: Twitter: https://twitter.com/diamedica Linkedin: https://linkedin.com/company/diamedica 

How to Camouflage a Virus: The Latest in Gene Therapy with Genine Winslow

 
 
Genine Winslow, the CEO and Co-founder of Chameleon Biosciences, a biotechnology company focused on safer, more effective gene therapies joins eHealth Radio and the Health News Channel.
Chameleon’s (patent pending) EVADER™ platform is helping to make it possible to treat people who previously could not be treated with gene therapy, especially children with genetic diseases such as severe Hemophilia B.
Listen to host Eric Dye & guests Genine Winslow discuss the following:
Obviously viruses are on everyone’s mind right now. The truth is that while viruses can be deadly such as in the case of COVID-19, gene therapy actually uses viruses as treatment vehicles for genetic diseases. Can you explain what it is about viruses that makes them ideal for treating genetic diseases?
As I understand it, Chameleon’s work focuses on treatments for people who can’t be treated with conventional gene therapies--why is it that some people, especially children, are untreatable?
Going into detail--back to COVID-19--the vaccines so many of us are getting are designed to prime our immune systems to help us detect and fight COVID-19. Chameleon’s work sounds like the opposite goal--to help viruses get past a person’s immune system multiple times. Talk about the science in that--where did the idea come from?
At Chameleon, you’ve developed an innovation called EVADER™. Can you explain (in simplified terms) what EVADER does to get around the issues you just described?
Obviously getting to market for something like EVADER is something that takes a lot of time and testing and funding. Can you tell us where Chameleon is in the process?
You’ve worked for many different groups as a scientist and now you run your own company. To all the managers and leaders out there, what is it that you would say scientists need in the workplace to be able to do their best work?
Genine Winslow is the CEO and co-founder of Chameleon Biosciences, a biotechnology company she founded in 2017 focused on safer, more effective gene therapies. At Chameleon, Genine combines her backgrounds in both immunology and gene therapy to engineer a next generation AAV based vector for systemic repeat dosing for children and adults who today cannot be treated with conventional gene therapies. Prior to Chameleon, Winslow has led gene therapy scientific initiatives at multiple companies including Audentes Therapeutics, BioMarin, BlueBird Bio, and Cell Genesys.
 
 
Website: https://chameleonbiosci.com 
Social Media Links: Twitter: https://twitter.com/ChameleonBiosci Linkedin: https://linkedin.com/company/chameleon-biosciences-inc 

Innovative and Better for your Passsover from Kosher.com: Manischewitz and other great Kosher Brands

 
 
Shani Seidman, the Chief Marketing Officer for Kayco Kosher, the leading Kosher Brand company in the United States housing hundreds of well-known Kosher brands joins eHealth Radio and the Health News and Nutrition Channels.
Listen to host Eric Dye & guests Shani Seidman discuss the following:
As Passover approaches tell us what kinds of foods are traditional and why? 
Lets talk about Kosher.com – which is part of Kayco Kosher, what is Kosher.com and what can people expect on here in the way of better for you products and recipes as we approach Passover?
Tell us about some of the Better For Your products from Kayco starting with  Manischewitz the leading maker of the traditional Matzo and what is new from them?
You also have a Better For You Brand called Heaven & Earth, tell us about those products
In addition, Tuscanini – from Italy – tell us about that brand and products.
Shani Seidman is the Chief Marketing Officers for Kayco Kosher, the leading Kosher Brand company in the United States housing hundreds of well-known Kosher brands. Brands under the Kayco Kosher umbrella include Gefen; Heaven & Earth; Manischewitz; and Tuscanini, to name a few. Shani leads the marketing and innovation of these brands as well as leads strategy for Kosher.com , the leading resource for all things Kosher, including recipes, products, and video content geared toward everyone from those keeping kosher to those who just want to learn more about the tradition.
 
Websites: www.kayco.com | www.kosher.com | Passover.com 
Social Media Links: Instagram: https://instagram.com/kosherdotcom Facebook: https://facebook.com/kosherdotcom 

Vetster and the Pet Tele-health Medicine Market with Dr. Sarah Machell

 
 
Vetster’s Medical Director Dr. Sarah Machell joins eHealth Radio and the Animal Health and Tele-Health Medicine Channels. Vetser has helped improve access to veterinary care and services, and has stepped forward to help bridge the care gap for pet owners and veterinarians.
Listen to interview with host Eric Michaels and guest Dr. Sarah Machell discuss the following:
Tell us about Vetster. What is the platform and who uses it?
How does Vetster work?
We have heard that many vet offices are closing across the country due to staffing issues etc. In your professional opinion, why is that and does Vetster help close that gap?
Is Vetster mainly for sick visits or should pet owners be getting periodic wellness checks for their pets and how often should they be getting them?
Can I see the same vet every time or will I be assigned to different vets?
What is the primary differentiator between Vetster and say other telehealth vet medicine platforms out there?
With the pandemic being an ongoing concern, do you see the future of pet healthcare being telemedicine or is there ever a time to go in and see a vet?
Can Vetster prescribe prescriptions for pets?
Where can one go to sign up for Vetster?
Dr. Sarah Machell is a licensed, practicing veterinarian a 1997 graduate of the Ontario Veterinary College, University of Guelph. She brings 18 years of experience in the establishment & growth of 2 successful small businesses in Oakville, Ontario; a small animal veterinary practice with 20 employees & an adjunct retail pet store.
 
 
Website: https://vetster.com
Social Media Links: Facebook: https://facebook.com/vetster.incTwitter: https://twitter.com/vetster